858647-72-0

Basic information

• Product Name: N'-(2,3-dihydroxybenzylidene)benzohydrazide
• Synonyms: N'-(2,3-dihydroxybenzylidene)benzohydrazide
• CAS NO: 858647-72-0
• Molecular Formula: C₁₄H₁₂N₂O₃
• Molecular Weight: 256.25668
• Mol File: 858647-72-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N'-(2,3-dihydroxybenzylidene)benzohydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: N'-(2,3-dihydroxybenzylidene)benzohydrazide(858647-72-0)
• EPA Substance Registry System: N'-(2,3-dihydroxybenzylidene)benzohydrazide(858647-72-0)

Safety Data

• Hazardous Substances Data: 858647-72-0(Hazardous Substances Data)

Upstream product

• 24677-78-9 2,3-dihydroxybenzaldehyde 
• 613-94-5 benzoic acid hydrazide 
• 54-85-3 isoniazid 
• 93-58-3 benzoic acid methyl ester 

Downstream Products

• 1242283-07-3 (2'E)-tetramethyl 2,2'-[3-({2-benzoyl-2-[(Z)-1,4-dimethoxy-1,4-dioxobut-2-en-2-yl]hydrazono}methyl)-1,2-phenylene]bis(oxy)dimaleate 

Relevant articles and documents

Syntheses, characterization, and crystal structures of few dioxomolybdenum(VI) complexes incorporating tridentate hydrazones

Three new cis-dioxomolybdenum(VI) complexes, [MoO2(L1)(CH3OH)] (1), [MoO2(L2)(CH3OH)] (2), and [MoO2(L3)(CH3OH)] (3) have been synthesized using three diffe

2,3,4-Trihydroxybenzyl-hydrazide analogues as novel potent coxsackievirus B3 3C protease inhibitors

Human coxsackievirus B3 (CVB3) 3C protease plays an essential role in the viral replication of CVB3, which is a non-enveloped and positive single-stranded RNA virus belonging to Picornaviridae family, causing acute viral myocarditis mainly in children. During optimization based on SAR studies of benserazide (3), which was reported as a novel anti-CVB3 3Cpro agent from a screening of compound libraries, the 2,3,4-trihydroxybenzyl moiety of 3 was identified as a key pharmacophore for inhibitory activity against CVB3 3Cpro. Further optimization was performed by the introduction of various aryl-alkyl substituted hydrazide moieties instead of the serine moiety of 3. Among the optimized compounds, 11Q, a 4-hydroxyphenylpentanehydrazide derivative, showed the most potent inhibitory activity (IC50 Combining double low line 0.07 μM). Enzyme kinetics studies indicated that 11Q exhibited a mixed inhibitory mechanism of action. The antiviral activity against CVB3 was confirmed using the further derived analogue (14b) with more cell permeable valeryl ester group at the 2,3,4-trihydroxy moiety.

Design, synthesis and in vitro antimalarial activity of an acylhydrazone library

A library of acylhydrazone iron chelators was synthesized and tested for its ability to inhibit the growth of a chloroquine-resistant strain of Plasmodium falciparum. Some of these new compounds are significantly more active than desferrioxamine DFO, the